Are Trump’s pharmaceutical policies a seismic revolution, or just hot air? Will he succeed in lowering drug prices in 2026? Will manufacturing shift to the US? And how will all of this impact Europe and China? ING's Diederik Stadig and Stephen Farrelly answer these questions and more in this week's THINK aloud.

In this podcast, ING's Diederik Stadig, Gerben Hieminga and Coco Zhang discuss the role of data centres in driving global economic growth, strategies to tackle the energy challenge, and what Europe must do to raise its game

In this podcast, ING's James Knightley and Padhraic Garvey discuss President Trump's efforts to steer monetary policy - and the economic narrative - through high-profile firings at the Federal Reserve and Bureau of Labor Statistics.

The Trump administration has imposed a 15% tariff on EU pharmaceuticals and threatened even steeper levies elsewhere. At the same time, however, the government has issued ultimatums to 17 companies to cut drug costs. In this podcast, ING's Diederik Stadig explains why these competing goals cannot be reconciled, and what the strategy means for the industry - and for consumers in the US and Europe.

The US dollar's historic plunge has sent ripples across global currency markets. As its dominance falters, investors everywhere are asking, how far could it fall - and who stands to gain? In this week's THINK aloud, a replay of our live webinar, ING's Chris Turner, Francesco Pesole, Frantisek Taborsky, and Deepali Bhargava share their views.

President Donald Trump this week delayed the planned 9 July tariff hikes on US imports, notifying 22 countries that rates could rise as much as 50% on 1 August.

The White House had paused these measures for 90 days to pursue trade deals, but since Trump’s so-called Liberation Day announcement on 2 April, only three agreements have been reached.

ING’s Inga Fechner says the new deadline, which Trump has described as firm, but not 100% firm, prolongs the uncertainty for business and consumers around the world. James Knightley says this is weighing on US economic growth - with GDP forecasts for 2025 markedly lower than at the start of the year.

For now at least, markets are taking the news in stride, having recovered from the extreme volatility seen in April. But Padhraic Garvey says tariff-induced inflation and worries about fiscal sustainability present a difficult backdrop for US Treasuries.

In this week’s THINK aloud, a replay of our live webinar, we look at the future of so-called reciprocal tariffs, potential sector-specific tariffs, the legal uncertainties ahead, the threat of retaliation and the broader impact on the global economy and financial markets.

A US-brokered ceasefire between Iran and Israel sent oil prices tumbling this week, as traders and investors bet that the bombing campaigns are over and that the crucial Strait of Hormuz - through which 21 million barrels of oil pass each day -will not be disrupted.

The drop in oil prices is good news for global growth – and for inflation, potentially giving central banks in Europe and the US some breathing room to cut interest rates later this year.

But is the crisis really over? Or have the risks simply evolved?

With geopolitical tensions still simmering, do investors ned to price in a more persistent risk premium?

In this podcast, ING's Warren Patterson unpacks the outlook for oil, Bert Colijn explores the economic impact, and Francesceo Pesole looks at what it all means for the dollar.

President Trump's unpredictable trade policy has undermined confidence and deepened uncertainty across the global economy this year. In this podcast, ING's James Knightley, Carsten Brzeski, and James Smith discuss the outlook for the US, eurozone and UK economies in this new, uncharted territory while Chris Turner looks at the implications for financial markets.